- £3.42bn
- £4.40bn
- $3.16bn
- 75
- 65
- 48
- 72
REG - Hikma Pharmaceutical - Siggi Olafsson to step down as Chief Executive
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Results of EGM
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Share Buyback Programme
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Hikma updates Generics guidance for 2022
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
Announcement